Treatment with paliperidone palmitate according to clinical practice upon admission to acute units: shadow study

被引：0
|
作者：
Parellada, E. [1 ]
Bioque, M. [1 ]
Herrera, B. [2 ]
Garcia Dorado, M. [2 ]
机构：
[1] Hosp Clin Barcelona, Unitat Esquizofrenia Clin, Barcelona, Spain
[2] Janssen, Med Affairs Dept, Madrid, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70882-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.049
引用
收藏
页码：S551 / S551
页数：1
相关论文
共 50 条
  • [31] Initiation of three-monthly palmitate paliperidone long-acting formulation in French clinical practice: results from the OPTIMUS study
    Gary, C.
    Deal, C.
    Boursicot-Beuzelin, J.
    Guilton, P.
    Falissard, B.
    Giordana, J. Y.
    Fakra, E.
    Samalin, L.
    Bouju, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S456 - S457
  • [32] Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
    Such, Pedro
    Olivares, Jose Manuel
    Arias, Lizbeth
    Berg, Mette Troels
    Madera, Jessica
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 1881 - 1892
  • [33] Influence of paliperidone palmitate one-month treatment on the medication preference of Chinese patients with acute schizophrenia
    Si, T. M.
    Zhang, L. L.
    Feng, Y.
    Zhuo, J. M.
    Lu, H. F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S544 - S545
  • [34] Long acting paliperidone palmitate - a service evaluation of its use in clinical practice and its effects on hospital stay
    Pappa, S.
    Sahib, L.
    Larkin, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S502 - S503
  • [35] Paliperidone palmitate in patients affected by schizophrenia, non-acute but symptomatic, after failure of treatment with aripiprazole
    Bergmans, P.
    Hargarter, L.
    Cherubin, P.
    Rancans, E.
    Bez, Y.
    Parellada, E.
    Carpiniello, B.
    Vidailhet, P.
    Schreiner, A.
    EUROPEAN PSYCHIATRY, 2014, 29 (08) : 658 - 658
  • [36] SAFETY, TOLERABILITY AND TREATMENT RESPONSE WITH FLEXIBLE DOSES OF PALIPERIDONE PALMITATE IN NON-ACUTE PATIENTS WITH SCHIZOPHRENIA
    Schreiner, A.
    Hargarter, L.
    Bergmans, P.
    Cherubin, P.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [37] TREATMENT OF ACUTE DEPRIVATION SYNDROMES UPON ADMISSION TO THE PEDIATRIC HOSPITAL
    MENZEL, K
    MONATSSCHRIFT KINDERHEILKUNDE, 1984, 132 (09) : 758 - 758
  • [38] Therapeutic workshops telithromycin in daily practice in emergency admission and treatment units
    Potel, G
    PRESSE MEDICALE, 2003, 32 (19): : 904 - 905
  • [39] Functionality in patients with newly diagnosed schizophrenia treated with paliperidone palmitate 3-month formulation in real-world clinical practice study (TIME study)
    Garcia-Portilla, M. P.
    Gomez, F.
    Benito, A.
    Lopez, P.
    Garcia, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S470 - S471
  • [40] Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysis
    Kishi, Taro
    Sakuma, Kenji
    Iwata, Nakao
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
12345